A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer

A case of pathological complete response with liposomal irinotecan + 5-FU/LV for unresectable locally advanced pancreatic cancer

Abstract Background Pancreatic cancer has one of the worst prognoses of any all cancers. 5-FU/leucovorin + irinotecan + oxaliplatin (FOLFIRINOX), gemcitabine (GEM) plus nab-paclitaxel regimens have been recognized as global-standard, first-line treatments for patients with advanced pancreatic cancer...

Full description

Bibliographic Details
Main Authors: Koji Kikuchi, Akira Umemura, Hiroyuki Nitta, Hirokatsu Katagiri, Masao Nishiya, Noriyuki Uesugi, Tamotsu Sugai, Keisuke Imanari, Akira Sasaki
Format: Article
Language:English
Published: SpringerOpen 2022-10-01
Series:Surgical Case Reports
Subjects:
Liposomal irinotecan
Pancreatic ductal adenocarcinoma
Unresectable pancreatic cancer
Pathological complete response
Online Access:https://doi.org/10.1186/s40792-022-01549-9

Internet

https://doi.org/10.1186/s40792-022-01549-9

Similar Items